[33] [34] In 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on GLP-1 medication after an increase in reports to the agency's Yellow Card Scheme of acute pancreatitis, with fatalities, in patients taking semaglutide or tirzepatide, to warn of a small risk of developing severe acute pancreatitis
While human clinical data is still limited, the mechanism is compelling and the preclinical results are among the most impressive seen for any peptide-based hair treatment
Cardiometabolic markers also improved

John Munster Highland La Porte Clarksville Seymour Shelbyville Logansport New Castle Lebanon Huntington Jasper Vincennes Wichita Overland Park Kansas City Olathe Topeka Lawrence Shawnee Lenexa Manhattan Salina Hutchinson Leavenworth Leawood Dodge City Garden City Lexington-Fayette Bowling Green Owensboro Covington Richmond Georgetown Florence Nicholasville Hopkinsville Elizabethtown Independence Henderson Frankfort Jeffersontown Baltimore Columbia Germantown Silver Spring Waldorf Frederick Ellicott City Glen Burnie Rockville Gaithersburg Bethesda Dundalk Towson Bowie Aspen Hill Wheaton North Bethesda Severn Bel Air South Potomac Catonsville Odenton Hagerstown Essex Woodlawn Boston Worcester Springfield Cambridge Lowell Brockton New Bedford Quincy Lynn Fall River Newton Somerville Lawrence Framingham Haverhill Waltham Plymouth Malden Brookline Weymouth Town Taunton Medford Chicopee Revere Peabody Methuen Town Everett Arlington Attleboro Barnstable Town Billerica Salem Beverly Pittsfield Leominster Westfield Fitchburg Woburn Holyoke Amherst Chelsea Marlborough Shrewsbury Braintree Town Andover Natick Watertown Town Chelmsford Detroit Grand Rapids Warren Sterling Heights Ann Arbor Lansing Clinton Flint Dearborn Canton Livonia Macomb Troy Westland Shelby Farmington Hills Kalamazoo Wyoming Rochester Hills Southfield Waterford West Bloomfield Taylor Novi Pontiac Royal Oak St

Of 79 pharmacies identified, about 14% didnt disclose they were selling compounded versions, and nearly 37% implied or outright falsely claimed that the drugs were FDA-approved